secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001193125-23-173169
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma shareholders elect all 10 director nominees; all AGM proposals pass
--------------------------------------------------------------------------------

- All ten director nominees elected, with support ranging from 79.2% (Gregory Norden) to 99.7% (M. Germano Giuliani).
- Non-binding say-on-pay approved: 483.9M for (94.5% of votes cast excluding 22M broker non-votes).
- Ratification of Ernst & Young as independent auditor passed with 534.2M for (99.98%).
- UK statutory accounts and auditor reappointment also approved with >99% support; no broker non-votes on those proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312523173169/0001193125-23-173169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312523173169/d461066d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-173169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer